Search results for "helicobacter pylori."

showing 10 items of 172 documents

Helicobacter pylori gamma-glutamyl transpeptidase and vacuolating cytotoxin promote gastric persistence and immune tolerance

2013

Infection with the gastric bacterial pathogen Helicobacter pylori is typically contracted in early childhood and often persists for decades. The immunomodulatory properties of H. pylori that allow it to colonize humans persistently are believed to also account for H. pylori ’s protective effects against allergic and chronic inflammatory diseases. H. pylori infection efficiently reprograms dendritic cells (DCs) toward a tolerogenic phenotype and induces regulatory T cells (Tregs) with highly suppressive activity in models of allergen-induced asthma. We show here that two H. pylori virulence determinants, the γ-glutamyl transpeptidase GGT and the vacuolating cytotoxin VacA, contribute critic…

TransgeneVirulenceMice Transgenicbacterial virulence factorspersistence strategieshygiene hypothesisMicrobiologyImmune toleranceMice03 medical and health sciences0302 clinical medicineBacterial ProteinsIn vivoImmune ToleranceAnimalsGamma-glutamyltransferasehuman microbiotaPathogen030304 developmental biology0303 health sciences1000 MultidisciplinaryMultidisciplinaryHelicobacter pyloribiologyStomach10061 Institute of Molecular Cancer Researchgamma-GlutamyltransferaseBiological SciencesHelicobacter pyloribiology.organism_classificationbacterial infections and mycosesCoculture TechniquesIn vitrodigestive system diseases3. Good healthMice Inbred C57BLImmunologybiology.protein570 Life sciences; biology030211 gastroenterology & hepatologypersistent bacterial infection
researchProduct

258 Helicobacter Pylori Infection in Allergic Children

2010

Background and aims: Studies have suggested that Helicobacter pylori (H.pylori) infection could be considered as a protective factor against development of allergic illnesses. The goal of our study was to compare the prevalence of H. pylori infection in allergic patients and children without allergy. Methods: The total patient sample consisted of 147 children aged 1-10 yrs (mean age 5.2): 58 children had allergy diagnosis and 89 were healthy children or children with minor health problems. Parents were asked to bring a faecal samples of the child and to fill out a questionnaire (demographic data, socio-economical factors). Presence of active H. pylori infection was detected by stool antigen…

Univariate analysismedicine.medical_specialtyHelicobacter pylori infectionAllergybiologybusiness.industryCorisProtective factorDiseaseHelicobacter pyloribiology.organism_classificationLogistic regressionmedicine.diseaseInternal medicinePediatrics Perinatology and Child HealthMedicinebusinessPediatric Research
researchProduct

Verbessert die Therapie mit Levofloxacin die Helicobacter-pylori-Eradikation?

2008

biologybusiness.industryImmunologyGastroenterologyMedicineHelicobacter pyloribusinessbiology.organism_classificationZeitschrift für Gastroenterologie
researchProduct

Helicobacter pylori eradication and reinfection

1995

biologybusiness.industryMedicineGeneral MedicineHelicobacter pyloribusinessbiology.organism_classificationVirologyThe Lancet
researchProduct

TEST-AND-TREAT ANCHE PER LA POPOLAZIONE GERIATRICA CON HP-INFEZIONE?

2008

helicobacter pylori HP-infezione test and treat
researchProduct

Comparison of the impact of Helicobacter pylori eradication treatment with bismuth and non-bismuth quadruple regimens on the gut microbiota

2019

Background: Helicobacter pylori eradication requires a combination of antibiotics. The short and long-term effect of different H. pylori eradication regimens on the gut microbiota has received little attention. Aims: To evaluate and compare the impact of the two most frequently recommended first-line H. pylori eradication regimens — bismuth and non-bismuth quadruple regimens — on the gut microbiota. Patients and Methods: Two 14-day quadruple treatments were evaluated and compared: bismuth-based quadruple therapy (proton pump inhibitor, bismuth, tetracycline, and metronidazole) and non-bismuth quadruple “concomitant” therapy (proton pump inhibitor, amoxicillin, clarithromycin and metronidazo…

lcsh:R5-920bismuthmicrobiotalcsh:Diseases of the digestive system. Gastroenterologyproton pump inhibitorslcsh:RC799-869clarithromycinlcsh:Medicine (General)digestive systemhelicobacter pylori.antibioticsMicrobiota in Health and Disease
researchProduct

Data from: The role of morbidly obesity in the promotion of metabolic disruptions and non-alcoholic steatohepatitis by Helicobacter Pylori

2017

Helicobacter pylori (HP) infection has been associated to an increased rate of type 2 diabetes (T2D) and liver disease through its effect on insulin resistance and systemic inflammation. However, results are inconstant and no studies exist in morbidly obese patients, in which both insulin resistance and inflammation coexist. Material and Methods: Cross-sectional study to evaluate the relationship between HP infection and alterations in carbohydrate metabolism, lipid profile, inflammation markers, and liver disease in patients awaiting for bariatric surgery. HP infection was histologically assessed in gastric antrum biopsy from 416 subjects. Liver biopsy was also available in 93 subjects. Re…

medicine and health careglucose abnormalitiesHelicobacter pyloriMedicineType 2 diabetesObesitynon-alcoholic steatohepatitisLife sciences
researchProduct

Helicobacter pylori Infection and Risk Factors in Relation to Allergy in Children

2017

Purpose To analyze presence of Helicobacter pylori infection and environmental risk factors among children with and without allergy. Methods Parents of children at primary health care centres/kindergartens and allergologist consultation were asked to answer a questionnaire and to bring a faecal sample. H. pylori infection was detected by monoclonal stool antigen test. Prevalence of H. pylori infection and risk factors were compared between individuals with and without allergy using χ2 test, ANOVA test and parameters and logistic regression. Results Among 220 children (mean age, 4.7 years; ±standard deviation 2.3 years) H. pylori positivity was non-significantly lower among patients with all…

medicine.medical_specialtyAllergyAllergymedicine.medical_treatmentLogistic regression03 medical and health sciences0302 clinical medicineInternal medicineMedicineCaesarean section030212 general & internal medicineFamily historyHepatologybiologyHelicobacter pyloribusiness.industryGastroenterologyOdds ratioHelicobacter pylorimedicine.diseasebiology.organism_classificationConfidence interval030228 respiratory systemRisk factorsPediatrics Perinatology and Child HealthOriginal ArticlebusinessBreast feedingPediatric Gastroenterology, Hepatology & Nutrition
researchProduct

Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management…

2020

Background Experience in Helicobacter pylori eradication treatment of patients allergic to penicillin is very scarce. A triple combination with a PPI, clarithromycin (C), and metronidazole (M) is often prescribed as the first option, although more recently the use of a quadruple therapy with PPI, bismuth (B), tetracycline (T), and M has been recommended. Aim To evaluate the efficacy and safety of first-line and rescue treatments in patients allergic to penicillin in the "European Registry of H pylori management" (Hp-EuReg). Methods A systematic prospective registry of the clinical practice of European gastroenterologists (27 countries, 300 investigators) on the management of H pylori infect…

medicine.medical_specialtyAllergySettore MED/12 - GASTROENTEROLOGIAallergicPenicillinsGastroenterologyHelicobacter InfectionsDrug Hypersensitivity03 medical and health sciences0302 clinical medicineLevofloxacinMetronidazoleClarithromycinInternal medicinebismuthmedicineHumansProspective StudiesRegistriesAdverse effectlevofloxacinbiologyHelicobacter pyloribusiness.industrySettore MED/09 - MEDICINA INTERNAallergic ; allergy ; bismuth ; clarithromycin ; Helicobacter pylori ; levofloxacin ; penicillinGastroenterologyProton Pump InhibitorsGeneral MedicineTetracyclineHelicobacter pyloribiology.organism_classificationmedicine.diseaseallergyclarithromycinAnti-Bacterial Agents3. Good healthPenicillinMetronidazoleRegimenInfectious Diseasespenicillin030220 oncology & carcinogenesisDrug Therapy Combination030211 gastroenterology & hepatologybusinessmedicine.drug
researchProduct

Is Helicobacter pylori status relevant in the management of GORD?

2000

Summary There is growing interest in the relationship between H. pylori infection and gastro-oesophageal reflux disease (GORD). However, this relationship is complex, as yet not fully elucidated, and probably based on a multiplicity of factors. The prevalence of H. pylori infection in patients with GORD is similar, more often lower than in matched controls. There is a negative correlation between H. pylori infection and the severity of GORD. There are many hypothetical mechanisms by which H. pylori infection may protect from the development of GORD. Conversely, there are many possible mechanisms by which H. pylori infection could theoretically foster the GORD. Patients after H. pylori eradi…

medicine.medical_specialtyAtrophic gastritismedicine.drug_classProton-pump inhibitordigestive systemGastroenterologyInternal medicinemedicinePharmacology (medical)HelicobacterHepatologybiologybusiness.industryStomachdigestive oral and skin physiologyGastroenterologyIntestinal metaplasiaHelicobacter pylorimedicine.diseasebiology.organism_classificationdigestive system diseasesmedicine.anatomical_structureDysplasiaGastritismedicine.symptombusinessAlimentary Pharmacology & Therapeutics
researchProduct